Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2022 | Potential of anti-amyloid drugs for treating Alzheimer’s disease

Oscar López, MD, FAAN, University of Pittsburgh, Pittsburgh, PA, talks about the approval of aducanumab for treating patients with early-stage Alzheimer’s disease (AD) and discusses the potential of anti-amyloid drugs for treating early-stage AD. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.